Cat. #161805
UM-UC-6 (Human Bladder Transitional Cell Carcinoma) Cell Line
Cat. #: 161805
Availability: 8-10 weeks
Organism: Human
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: H. Grossman ; Anita Sabichi
Institute: University of Michigan
Primary Citation: Grossman et al. 1984. J Urol. 132(4):834-7. PMID: 6471236;Sabichi et al. 2006. J Urol. 175(3 Pt 1):1133-7. PMID: 16469639.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: UM-UC-6 (Human Bladder Transitional Cell Carcinoma) Cell Line
- Alternate name: UM-UC6; UMUC6; UC-6; University of Michigan-Urothelial Carcinoma-6
- Cancer: Genitourinary cancer
- Research fields: Cancer
- Organism: Human
- Growth properties: Adherent
- Crispr: No
- Description: UM-UC-6 was obtained by transurethral resection of a bladder transitional cell carcinoma found in a male patient. UM-UC-6 was found to produce tumours in athymic nude mice.
Handling
- Growth medium: Dulbecco's modified Eagle's medium (DMEM) containing 10% heat inactivated Fetal Bovine Serum (FBS) and were supplemented with 1% penicillin and streptomycin
- Temperature: 37° C
- Atmosphere: 5% CO2
- Shipping conditions: Dry ice
- Storage conditions: Liquid Nitrogen
- Cultured in antibiotics: Penicillin, Streptomycin
References
- Grossman et al. 1984. J Urol. 132(4):834-7. PMID: 6471236
- Sabichi et al. 2006. J Urol. 175(3 Pt 1):1133-7. PMID: 16469639.
